Stage IIA Prostate Cancer Completed Phase 2 Trials for Cilengitide (DB11890)

IndicationStatusPhase
DBCOND0028878 (Stage IIA Prostate Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00121238Cilengitide in Treating Patients With Prostate CancerTreatment